Fenbendazole Market 2028 By Product Type, Application and Geography | The Insight Partners

report image

Fenbendazole Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type (Powder, Tablet, Liquid Formulations) ; Application (Cattle, Sheep, Pig, Horse, Hens, Others) and Geography

Report Code: TIPRE00008628 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Fenbendazole is an anthelmintic used to treat common helminth infections, including ascarids, hookworms, whipworms, and a single species of tapeworm, taenia pisiformis.


Increase in the research and development of fenbendazole in the treatment of the disorders in animals and human is the major factor propelling the market growth. For instance, Researchers at the National Centre for Human Genome Studies and Research (NCHGSR), have reported that fenbendazole has a good potential for development as an effective anti-cancer agent.


The "Global Fenbendazole Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Fenbendazole Market with detailed market segmentation by product type, application, and geography. The Global Fenbendazole Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Fenbendazole Market players and offers key trends and opportunities in the market.


The Global Fenbendazole Market is segmented on the basis of product type, and application. On the basis of product type, market can be classified as powder, tablet, and liquid formulations. Based on application the market is segmented into cattle, sheep, pig, horse, hens, others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Fenbendazole Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Fenbendazole Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Fenbendazole Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Fenbendazole Market in these regions.

Get more information on this report :


The report covers key developments in the Fenbendazole Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Fenbendazole Market are anticipated to lucrative growth opportunities in the future with the rising demand for Fenbendazole Market in the global market. Below mentioned is the list of few companies engaged in the Fenbendazole Market.

The report also includes the profiles of key Fenbendazole Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
- Hubei KangBaoTai Fine Chemical Co., Ltd
- Merck Sharp & Dohme Corp.
- Leo Bio-care Private Limited
- Supharma Chem
- Intervet Inc.
- LASA Supergenerics Limited
- Jiangsu Quality Horizons Pharmtech Co., Ltd
- Phibro Animal Health

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
2. Hubei KangBaoTai Fine Chemical Co., Ltd
3. Merck Sharp & Dohme Corp.
4. Leo Bio-care Private Limited
5. Supharma Chem
6. Intervet Inc.
7. LASA Supergenerics Limited
8. Jiangsu Quality Horizons Pharmtech Co., Ltd
9. Phibro Animal Health

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount